{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:44:40Z","timestamp":1760100280097},"reference-count":26,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annales de Cardiologie et d'Ang\u00e9iologie"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1016\/j.ancard.2010.07.005","type":"journal-article","created":{"date-parts":[[2010,8,4]],"date-time":"2010-08-04T08:50:11Z","timestamp":1280911811000},"page":"196-204","source":"Crossref","is-referenced-by-count":4,"title":["Endoproth\u00e8ses coronaires actives\u00a0: respectons-nous les recommandations de la Soci\u00e9t\u00e9 fran\u00e7aise de cardiologie et de la Haute Autorit\u00e9 de sant\u00e9 dans notre pratique quotidienne\u00a0?"],"prefix":"10.1016","volume":"59","author":[{"given":"E.","family":"Puymirat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Chaib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Chaudeurge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Trinquart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Ledru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Durand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Danchin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Blanchard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ancard.2010.07.005_bib1","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1056\/NEJMoa035071","article-title":"Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. SIRIUS Investigators","volume":"349","author":"Moses","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ancard.2010.07.005_bib2","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1161\/01.CIR.0000127110.49192.72","article-title":"TAXUS-IV Investigators. One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trial","volume":"109","author":"Stone","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ancard.2010.07.005_bib3","doi-asserted-by":"crossref","unstructured":"Jim\u00e9nez-Quevedo P, Sabat\u00e9 M, et al. for the DIABETES Investigators. Long-term clinical benefit of sirolimus-eluting stent implantation in diabetic patients with de novo coronary stenoses: long-term results of the DIABETES trial. Eur Heart J. 2007;16:1946\u201352.","DOI":"10.1093\/eurheartj\/ehm197"},{"key":"10.1016\/j.ancard.2010.07.005_bib4","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1093\/eurheartj\/ehm424","article-title":"TAXUS VI 2-year follow-up: randomized comparison of polymer-based paclitaxeleluting with bare metal stents for treatment of long, complex lesions","volume":"28","author":"Grube","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ancard.2010.07.005_bib5","unstructured":"Mehilli J, Kastrati A et al. for the ISAR-DESIRE Study. Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis. A randomized controlled trial. JAMA. 2005;293:165\u201371."},{"issue":"10","key":"10.1016\/j.ancard.2010.07.005_bib6","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa066633","article-title":"A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents","volume":"356","author":"Spaulding","year":"2007","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.ancard.2010.07.005_bib7","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1056\/NEJMoa067193","article-title":"Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents","volume":"356","author":"Stone","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ancard.2010.07.005_bib8","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1056\/NEJMoa067484","article-title":"Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents","volume":"356","author":"Kastrati","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ancard.2010.07.005_bib9","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(07)61444-5","article-title":"Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis","volume":"370","author":"Stettler","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ancard.2010.07.005_bib10","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1056\/NEJMoa067731","article-title":"Stent thrombosis in randomized clinical trials of drug-eluting stents","volume":"356","author":"Mauri","year":"2007","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.ancard.2010.07.005_bib11","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1161\/01.CIR.0000062700.42060.6F","article-title":"Images in cardiovascular medicine. Sirolimus-eluting stent implanted in human coronary artery for 16 months: pathological findings","volume":"107","author":"Guagliumi","year":"2003","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.ancard.2010.07.005_bib12","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/00019501-200409000-00003","article-title":"Drug-eluting stents: caution and concerns for long-term outcome","volume":"15","author":"Virmani","year":"2004","journal-title":"Coron Artery Dis"},{"issue":"2","key":"10.1016\/j.ancard.2010.07.005_bib13","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1541-9215.2004.03632.x","article-title":"Drug-eluting stents: are they really safe?","volume":"2","author":"Virmani","year":"2004","journal-title":"Am Heart Hosp J"},{"issue":"24","key":"10.1016\/j.ancard.2010.07.005_bib14","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1161\/CIRCULATIONAHA.106.618066","article-title":"Prevalence. Predictors and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results From the PREMIER Registry","volume":"113","author":"Spertus","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.ancard.2010.07.005_bib15","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1016\/S0735-1097(02)02597-4","article-title":"Clinical restenosis after coronary stenting: perspectives from multicenter clinical trials","volume":"40","author":"Cutlip","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ancard.2010.07.005_bib16","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1161\/CIRCULATIONAHA.106.618066","article-title":"Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry","volume":"113","author":"Spertus","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.ancard.2010.07.005_bib17","doi-asserted-by":"crossref","unstructured":"ACC\/AHA 2007 guidelines for the management of patients with unstable angina\/non-ST-elevation myocardial infarction: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. Circulation. 2007;116(7):e148\u2013304.","DOI":"10.1161\/CIRCULATIONAHA.107.181940"},{"key":"10.1016\/j.ancard.2010.07.005_bib18","unstructured":"Food and Drug Administration. http:\/\/www.fda.gov\/cdrh\/news\/010407.html."},{"key":"10.1016\/j.ancard.2010.07.005_bib19","unstructured":"Danchin N, Blanchard D, Chevalier B, Eltchaninoff H, Ferri\u00e8res J, Steg PG, et al. Utilisation des stents actifs. Consensus d\u2019experts de la Soci\u00e9t\u00e9 fran\u00e7aise de cardiologie. Octobre 2007."},{"key":"10.1016\/j.ancard.2010.07.005_bib20","doi-asserted-by":"crossref","unstructured":"Bhatt DL, Topol EJ. Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance Executive Committee. Clopidogrel added to aspirin versus aspirin alone in secondary prevention and high-risk primary prevention: rationale and design of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial. Am Heart J 2004;148:263\u20138.","DOI":"10.1016\/j.ahj.2004.03.028"},{"key":"10.1016\/j.ancard.2010.07.005_bib21","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0140-6736(07)60314-6","article-title":"Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study","volume":"369","author":"Daemen","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ancard.2010.07.005_bib22","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0140-6736(05)67221-2","article-title":"for the BASKET Investigators. Incremental cost-effectiveness of drug-eluting stents compared with a third-generation bare-metal stent in a real world setting: randomised Basel Stent Kosten Effektivit\u00e4ts Trial (BASKET)","volume":"366","author":"Kaiser","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ancard.2010.07.005_bib23","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1056\/NEJMoa067193","article-title":"Safety and efficacy of sirolimus and paclitaxel-eluting stents","volume":"356","author":"Stone","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ancard.2010.07.005_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacc.2007.04.051","article-title":"Risk factors for stent thrombosis after implantation of sirolimus-eluting stents in diabetic and nondiabetic patients. The EVASTENT Matched-Cohort Registry","author":"Machecourt","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ancard.2010.07.005_bib25","doi-asserted-by":"crossref","unstructured":"Win HK for the EVENT Registry Investigators. Clinical outcomes and stent thrombosis following off-label use of drug-eluting stents. JAMA 2007;297:2001.","DOI":"10.1001\/jama.297.18.2001"},{"key":"10.1016\/j.ancard.2010.07.005_bib26","doi-asserted-by":"crossref","unstructured":"Manzo-Silberman S, Varenne O, Spaulding C. Limites des stents actifs. Annales Cardiologie d\u2019Ang\u00e9iologie 2007;56:48\u201355.","DOI":"10.1016\/S0003-3928(07)80004-7"}],"container-title":["Annales de Cardiologie et d'Ang\u00e9iologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003392810000855?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003392810000855?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T15:44:36Z","timestamp":1685720676000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003392810000855"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["S0003392810000855"],"URL":"https:\/\/doi.org\/10.1016\/j.ancard.2010.07.005","relation":{},"ISSN":["0003-3928"],"issn-type":[{"value":"0003-3928","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]}}}